Related references
Note: Only part of the references are listed.The changing epidemiology of carbapenemase-producing Klebsiella pneumoniae in Italy: toward polyclonal evolution with emergence of high-risk lineages
Vincenzo Di Pilato et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)
Bloodstream infection caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam: epidemiology and genomic characterization
P. Gaibani et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Different phenotypic expression of KPC β-lactamase variants and challenges in their detection
Saoussen Oueslati et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Ceftazidime-avibactam susceptible to resistant KPC-producing Enterobacterales bloodstream infections: an observational study
Marco Iannaccone et al.
JOURNAL OF CHEMOTHERAPY (2020)
KPC-50 Confers Resistance to Ceftazidime-Avibactam Associated with Reduced Carbapenemase Activity
Laurent Poirel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Emergence of ceftazidime/avibactam resistance in KPC-8-producing Klebsiella pneumoniae in South America
J. Garcia et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Evaluation of five carbapenemase detection assays for Enterobacteriaceae harbouring bla(KPC) variants associated with ceftazidime/avibactam resistance
Paolo Gaibani et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Bloodstream infection by two subpopulations of Klebsiella pneumoniae ST1685 carrying KPC-33 or KPC-14 following ceftazidime/avibactam treatment: considerations regarding acquired heteroresistance and choice of carbapenemase detection assay
Gabriele Bianco et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
RESIST-5 OOKNV and NG-Test Carba 5 assays for the rapid detection of carbapenemase-producing Enterobacterales from positive blood cultures: a comparative study
G. Bianco et al.
JOURNAL OF HOSPITAL INFECTION (2020)
A Ceftazidime-Avibactam-Resistant and Carbapenem-Susceptible Klebsiella pneumoniae Strain Harboring blaKPC-14 Isolated in New York City
Siqiang Niu et al.
MSPHERE (2020)
Genomic characterization of a KPC-23-producing Klebsiella pneumoniae ST258 clinical isolate resistant to ceftazidime-avibactam
I. Galani et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
Unravelling ceftazidime/avibactam resistance of KPC-28, a KPC-2 variant lacking carbapenemase activity
Saoussen Oueslati et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Phenotypic, Biochemical, and Genetic Analysis of KPC-41, a KPC-3 Variant Conferring Resistance to Ceftazidime-Avibactam and Exhibiting Reduced Carbapenemase Activity
Linda Mueller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment
Paolo Gaibani et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace
Latania K. Logan et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Impaired Inhibition by Avibactam and Resistance to the Ceftazidime-Avibactam Combination Due to the D179Y Substitution in the KPC-2 β-Lactamase
Fabrice Compain et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
In Vitro Selection of Meropenem Resistance among Ceftazidime-Avibactam-Resistant, Meropenem-Susceptible Klebsiella pneumoniae Isolates with Variant KPC-3 Carbapenemases
Ryan K. Shields et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Mutations in blaKPC-3 That Confer Ceftazidime-Avibactam Resistance Encode Novel KPC-3 Variants That Function as Extended-Spectrum β-Lactamases
Ghady Haidar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Ceftazidime-Avibactam: a Novel Cephalosporin/beta-lactamase Inhibitor Combination
George G. Zhanel et al.
DRUGS (2013)
Share Paper
